entertainment -WSS

entertainment

author：Wikipedia 2025-10-01 14:20:16 - browse：44

DENVER — He could have been a rock star, a religious icon, the way ecstatic applause from thousands of attendees greeted the man dressed in a crisp, all-white suit as he strode onto a backlit stage. He was neither. This was Rick Doblin, the founder and evangelist of a movement to legalize psychedelic MDMA and bring the drug into mainstream medicine.

The scene in a Denver conference hall last week was a world away from the first conference Multidisciplinary Association for Psychedelic Studies (MAPS) held in 1990, when Doblin spoke alongside Timothy Leary — the ex-Harvard professor who popularized the phrase “turn on, tune in, and drop out.” That was just a few years after MDMA, also known as ecstasy, was criminalized, deemed a Schedule 1 drug “of no medical use.”

Now, as MAPS nears its goal of winning Food and Drug Administration approval for MDMA as a treatment for post-traumatic stress disorder, the perpetually smiling and energetic Doblin is basking in the adoration from both legions of “psychonauts” and unlikely yet powerful allies. “I literally love Rick Doblin,” the conservative Republican and former Texas governor Rick Perry told the audience in Denver.

It was a seemingly triumphant occasion. But even as Doblin is in sniffing distance of his lifelong quest, his once counter-cultural organization is grappling with the pressures of having to operate in the capitalist pharmaceutical sphere. MAPS was founded in 1986 as a nonprofit with deep-seated ideals. Doblin developed an “anti-patent” strategy, putting discoveries in the public domain so they couldn’t be claimed as intellectual property. He raised money to fund clinical trials of MDMA from like-minded wealthy donors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： One Duchenne patient's bittersweet hope for new treatment

focus

WSS

Presidential fundraising highlights so far: Trump brings in more than DeSantis

One Duchenne patient's bittersweet hope for new treatment

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Eisai exec who led development of Alzheimer’s drug to retire

Watch the official trailer for 'Ahsoka' series

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

hotspot

entertainment

focus

Bright Health sells Medicare Advantage business to Molina

Eisai exec who led development of Alzheimer’s drug to retire

Medicare details structure of new drug price negotiation program

The aspartame in Diet Coke probably isn’t giving you cancer

United colonoscopy coverage change 'may cost lives,' doctors say

Medicare wants to send $9 billion to 340B hospitals

Psychedelics group wrestles with new pharma identity

Companies helping big Covid

State Dept. review finds Biden bears some blame for Afghanistan failures

Recent heat wave in the Mediterranean caused by climate change: Study

hotspot

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

After half a century, Israel moves to evict squatter from his cave home on the beach

Biden targets hefty hospital 'facility fees' that often surprise patients

Medicare wants to send $9 billion to 340B hospitals

Superbugs, antibiotic resistance get scrutiny in congress

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

hotspot

focus

focus

entertainment